Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Seizures: Classification01:13

Seizures: Classification

2.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial factors do not explain discrepancy between daily diary and one-week retrospective reports of pain.

Pain·2026
Same author

Domains of Psychosocial Risk in School-Aged Cochlear Implant Users.

Journal of speech, language, and hearing research : JSLHR·2026
Same author

Signatures of adaptive memory search: How early linguistic input shapes strategic use of lexical information.

Journal of experimental psychology. General·2026
Same author

Multicenter randomized controlled trial of cognitive-behavioral, exercise-based, and combined interventions for juvenile fibromyalgia.

Pain·2026
Same author

Preliminary Validation of Two Brief Screening Measures for Eating Disorders in Adults with Chronic Pain.

Journal of clinical psychology in medical settings·2025
Same author

Rethinking psychological treatment targets for pediatric rumination syndrome: Clinical implications from a case series analysis.

JPGN reports·2025

Related Experiment Video

Updated: Mar 24, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges.

Amy E Williams1, Julianne M Giust1, William G Kronenberger1

  • 1Department of Psychiatry, Riley Child and Adolescent Psychiatry Clinic, Indiana University School of Medicine, Indiana University Health Physicians, Indianapolis, IN, USA.

Neuropsychiatric Disease and Treatment
|March 2, 2016
PubMed
Summary

Attention-deficit hyperactivity disorder (ADHD) is common in children with epilepsy, affecting 20%-50% of patients. This review covers ADHD prevalence, symptoms, and treatments in pediatric epilepsy.

Keywords:
ADHDchildrenepilepsyseizure disorder

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

26.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

26.0K

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Epileptology

Background:

  • Attention-deficit hyperactivity disorder (ADHD) affects 7%-9% of children generally.
  • Comorbid ADHD is significantly more prevalent in children with epilepsy, ranging from 20% to 50%.

Purpose of the Study:

  • To review the prevalence of ADHD in pediatric epilepsy populations.
  • To examine ADHD symptom presentation and attention deficits in children with epilepsy.
  • To discuss evidence-based treatments for ADHD in this comorbid population.

Main Methods:

  • Literature review of studies on ADHD in pediatric epilepsy.
  • Analysis of data on ADHD prevalence and symptomology.
  • Synthesis of information on treatment strategies for comorbid ADHD and epilepsy.

Main Results:

  • Children with epilepsy exhibit substantially higher rates of ADHD compared to the general pediatric population.
  • Specific patterns of ADHD symptoms and attention deficits are observed in children with epilepsy.
  • Evidence-based treatment guidelines for managing comorbid ADHD in pediatric epilepsy are identified.

Conclusions:

  • ADHD is a frequent comorbidity in pediatric epilepsy requiring specific clinical attention.
  • Understanding the unique presentation of ADHD in epilepsy is crucial for effective management.
  • Tailored, evidence-based treatment approaches are necessary for children with both ADHD and epilepsy.